Report: Cell technology, cell therapy, tissue engineering and gene therapy in Japan

About the Report

This report is primarily concerned with developments, market trends and regulations within the Japanese cell technology, cell therapy, tissue engineering and gene therapy sectors. It begins by outlining Japan's academic landscape and key research hubs within these various fields. It then analyses in detail the Japanese Society for Regenerative Medicine and also examines Japanese government policy and regulations regarding this topic. This report also provides a comparative analysis of EU, Japanese and US regulations, as well as a list of opportunities, access points and potential obstacles for EU SMEs hoping to enter this market in Japan. 

About the Expert

Professor Rolf Schmid is a consultant with over 40 years’ experience in biotechnology-related R&D and business. Click here to access his profile.